Background-Limitations in the predictive value of negative exercise echocardiography in type 2 diabetes mellitus has been linked to a reduced end-systolic pressure-volume response (ESPVR). We sought whether abnormal ESPVR reflected subclinical diabetic heart disease by examining the association between the ESPVR and markers of myocardial dysfunction and to establish if the change (⌬) or peak systolic blood pressure/end-systolic left ventricular volume ratio (SP/ESV) is a better marker of contractile reserve in type 2 diabetes mellitus. Methods and Results-Resting and exercise echocardiography was performed in 167 apparently healthy patients with type 2 diabetes mellitus (97 men; age, 55Ϯ10 years) without ischemia, other cardiac disease, or noncardiac complications of diabetes. Standard echocardiographic and color tissue Doppler measures (early diastolic tissue velocity, strain, and strain rate) were acquired at baseline and peak stress in apical long-axis views. Calibrated integrated backscatter was calculated from a resting parasternal long-axis view. ⌬SP/ESV was calculated as [(peak stress SP/ESV)Ϫ(rest SP/ESV)]. The 83 subjects who demonstrated a ⌬SP/ESV Յ12 mm Hg/mL/m 2 after exercise were older and had lower peak heart rate, resting diastolic and stress systolic tissue velocity, stress ejection fraction, and exercise capacity than the remainder. There was no significant association between ⌬SP/ESV and metabolic derangement or echocardiographic measures of deformation or backscatter. Change in Sm and stress ejection fraction were independent correlates of ⌬SP/ESV. Conclusions-⌬SP/ESV ratio is associated with established features of subclinical diabetic heart disease as well as determinants of contractile reserve (peak hemodynamic response and stress systolic function). Peak ESPVR is poorly associated with markers of myocardial dysfunction. (Circ Cardiovasc Imaging. 2010;3:443-449.)
T he negative predictive value of exercise stress echocardiography (ExE) for exclusion of underlying myocardial ischemia in type 2 diabetes mellitus (T2DM) is reduced compared with the nondiabetic population. 1 This may reflect the accelerated atherosclerosis of T2DM that limits the "warranty" of a negative ExE, although the development of dyspnea and exercise intolerance may be due to underlying diabetic heart disease (DHD) in the absence of coronary artery disease (CAD). If this were the case, the assessment of myocardial contractility and left ventricular (LV) contractile reserve might further stratify the risk of myocardial dysfunction in this population.
Clinical Perspective on p 449
Several noninvasive methods have been explored to quantify myocardial contractility and contractile reserve. All modalities exploit the general premise that tension increases with increased stimulation frequency as described in 1871 as the Bowditch treppe (positive staircase) phenomenon. 2 More recently, this concept has been applied more specifically to myocardium, with heart rate-dependent variation in myocardial contractility being expressed as the Force-Frequency Relation (FFR). 3 Numerous noninvasive echocardiographic methods have been used to identify latent LV dysfunction by unmasking limited contractile reserve, including the change in LV ejection fraction (LVEF) and change in LV end-systolic volume (LVESV) index as measures of contractile reserve. 4 The end-systolic pressurevolume-ratio (ESPVR, the ratio of the peak systolic pressure [SP] to the LVESV indexed for body surface area) 5, 6 has been of increasing interest as a noninvasive measure of contractility as, unlike the former methods, this technique is predominantly afterload-independent. 7 Assessment of contractile reserve using this method has also been found to be superior for prognostic stratification than either change in LVEF or change in LVESV. 7 Several techniques including dobutamine infusion 8 and graded bicycle exercise 9 have been used to examine ESPVR. The FFR curve (ESPVR plotted against heart rate) is reduced in CAD and dilated cardiomyopathy, with a biphasic curve also noted in the setting of myocardial ischemia. 9,10 Isolated chronotropic stimu-lation with incremental pacing produces similar FFR curve findings. 10 A flat or biphasic FFR curve is associated with increased cardiac death and major adverse cardiac events, 8 whereas the change in SP to the LVESV (⌬SP/ESV) is an independent correlate of total events (death, heart failure admissions, and worsening New York Heart Association class). 7 In T2DM, a ⌬SP/ESV Յ12 mm Hg/mL/m 2 and a peak SP/ESV Յ28 mm Hg/mL/m 2 have been demonstrated to correlate with increased future events including death and major adverse cardiac events, 11 although the pathophysiology of this association is yet undetermined. We hypothesized that an abnormal ESPVR is associated with factors reflective of myocardial dysfunction and adverse prognosis in T2DM. Our aims were to determine if an abnormal exercise ESPVR reflects established features of subclinical DHD, to examine the association between the ESPVR and other markers of myocardial dysfunction, and to identify whether ⌬SP/ESV or peak SP/ESV is preferable as the better marker of impaired contractility in T2DM.
Methods

Subjects
We recruited 167 apparently healthy subjects (97 men; age, 55Ϯ10 years) from the hospital clinic and community with T2DM, without macrovascular or microvascular complications or valvular, congenital, hypertensive or ischemic heart disease. All subjects had a resting EF Ͼ50% according to the modified biplane Simpson method, no evidence of inducible macrovascular ischemia or preexisting scar reflective of CAD on treadmill ExE, and no atrial fibrillation or other sustained arrhythmias. Calcium channel blockers and ␤-blockers, angiotensin-converting enzyme inhibitors, and nitrates were withheld for at least 12 hours before ExE.
Demographic, Anthropometric, and Metabolic Data
Clinical data were collected regarding subject age, sex, basic anthropometry [to establish body mass index (BMI) and waist-to-hip circumference ratio], smoking status, and duration of T2DM. Fasting glucose, fasting insulin, HbA1c, creatinine, and lipid profiles were obtained before exercise after fasting for at least 8 hours and before administration of hypoglycemic agents or antihypertensive medications. Insulin resistance was determined with the homeostasis model assessment method. 12 Microalbuminuria, a marker of microvascular disease, was quantified by means of a random urinary albumin-to-creatinine ratio and defined as Ն2.5 g/mol (male) and Ն3.5 g/mol (female).
Hemodynamics
Baseline resting hemodynamic parameters included heart rate (HR) and systolic (SBP) and diastolic (DBP) blood pressure (from the right brachial artery) with a manual cuff sphygmomanometer. These same hemodynamic measures were followed throughout the exercise and recovery phases of ExE.
Exercise Capacity
Cardiorespiratory fitness was assessed by indirect calorimetry (Vmax29c, SensorMedics, Yorba Linda, Calif), which measured maximal oxygen consumption [VO 2max (mL/kg/min)] through a closed circuit breathing system during the maximal treadmill ExE test. Exercise capacity was also estimated based on the duration of treadmill exercise achieved using the standard equation: METsϭ{Speedϫ[0.1ϩ(Gradeϫ1.8)]ϩ3.5}/3.5.
Pressure-Volume Relationship
ESPVR was defined as the peak cuff SBP divided by the indexed LVESV (SP/ESV). The ⌬SP/ESV was determined by the SP/ESV ratio at peak stress less the SP/ESV ratio at rest. A prognostically significant abnormal pressure-volume response was defined as a Figure 1 . Method to determine the noninvasive pressure-volume relationship. Rest and peak exercise blood pressure (BP) is estimated via manual cuff sphygmomanometer to give the SBP and DBP. LVESV is measured in apical 4-chamber and 2-chamber windows to establish the Biplane LV ESV at rest and at peak stress (indexed for body surface area). The SBP and ESV at rest and stress are then used to determine the rest and peak SP/ESV ratios and ultimately the ⌬SP/ESV. ⌬SP/ESV ratio Յ12 mm Hg/mL/m 2 or a peak SP/ESV ratio Յ28 mm Hg/mL/m 2 (Figure 1 ). 11
Exercise Echocardiography
A standard commercially available cardiac ultrasound machine (Vivid 7 General Electric Medical Systems, Milwaukee, Wis) was used to perform M-mode and 2D resting echocardiograms. In addition to standard baseline parasternal and apical images, color tissue Doppler loops were captured for offline measurement of tissue Doppler imaging (TDI). The same image planes were reimaged for wall motion scoring and TDI parameter measurement after maximal treadmill exercise, and images were saved in raw data format.
Echocardiographic Data Analysis
Offline analysis was performed to assess chamber wall thickness, valvular morphology, chamber volumes, LVEF, backscatter, and TDI parameters. Ischemia was excluded based on the absence of inducible wall motion abnormalities on a standard 16-segment model at peak stress. The modified Simpson biplane method was used to measure LVESV and end-diastolic volume at rest and peak exercise. Conventional apical views (4-chamber, 2-chamber, and long-axis) in color TDI formats at rest and peak were used to obtain tissue velocity, strain, and strain rate curves from the 6 basal segments with standard commercial software (Echopac, GE Vingmed). Peak systolic tissue velocity (Sm) and peak early diastolic tissue velocity (Em) were calculated from tissue velocity curves created by placing a tissue Doppler sample volume at the septal annulus and lateral annulus of the mitral valve. An average value from 3 consecutive tissue velocity curves was established for both septal and lateral walls. The mean of these 2 values was used to determine overall tissue velocity. Strain and strain rate curves were derived from apical views in color TDI format by placing sample volumes in the midmyocardium of the 6 basal segments, tracking the position of the sample volume throughout the cardiac cycle. An average peak value from 3 consecutive curves was used to calculate both strain and strain rate. In all cases, the angle of incidence between the transducer and the wall of interest was maintained Ͻ20°.
Calibrated Integrated Backscatter Analysis
Calibrated integrated backscatter (cIB) was calculated by measuring the tissue intensity of the pericardium, posterior wall, and anteroseptum in a parasternal long-axis view (Echopac, GE Vingmed). cIB was calculated by subtracting mean pericardial IB intensity at end-diastole from mean IB intensity of the posterior wall and the anteroseptum, which were then averaged to establish the mean cIB. 
Interobserver and Intraobserver Variability
Both interobserver and intraobserver variability were assessed by repeat measurement of myocardial tissue velocity, strain, strain rate, and cIB on resting and peak stress echocardiographic images from 10 randomly selected subjects. The original observer was blinded to previous measurements performed at least 4 weeks before evaluation of reproducibility, whereas a second observer was blinded to the first observer's results to assess variability. In addition to the absolute difference between measurements, intraclass correlation coefficient was used to determine overall variability. Using standard statistical computer software (SPSS Inc, Chicago, Ill), this analysis of reliability was performed using a 2-way random effects model to assess absolute agreement. Interobserver and intraobserver variability of chamber volume measurement within our group has been previously validated. 13
Statistical Analysis
Results are expressed as meansϮSD or percentages. Analysis between defined categorical groups (⌬SP/ESV, peak SP/ESV) was performed using the Student independent t test for continuous variables and 2 test for categorical variables. Resting SP/ESV was analyzed as a continuous variable as normal cutoff values are undefined; the correlation of this with various clinical features was determined using the Pearson correlation. Independent associations were sought by using a stepwise forward selection method to build logistic or linear regression models of independent variables. Candidate variables for the models were selected from unadjusted correlates in Table 1 Table 2, and Table 3 that were significant at PϽ0.10 and did not express colinearity with each other or with the pressure-volume relationship. Statistical analysis was performed using standard statistical computer software (SPSS Inc, Chicago, Ill).
A probability value of 0.05 was deemed statistically significant.
Results
Correlates of Abnormal ⌬SP/ESV
Of the 167 subjects, 84 demonstrated ⌬SP/ESV ratio Ͼ12 mm Hg/mL/m 2 from baseline to peak exercise stress, and 83 displayed ⌬SP/ESV ratio Յ12 mm Hg/mL/m 2 . A ⌬SP/ESV ratio Յ12 mm Hg/mL/m 2 correlated with increas- ing age but not with sex, duration of diabetes, smoking history, BMI, waist circumference, waist:hip circumference ratio, or hypoglycemic therapy (Table 1) . Angiotensinconverting enzyme inhibitor use was higher in this group, probably reflecting a greater use of antihypertensive treatment. There was no statistical difference in angiotensin II receptor blockers, ␤-blockers, or statin therapy between groups. Metabolic parameters (Table 1) were not worse in the lower pressure-volume ratio group, with HbA1c actually being lower. Of note, prevalence of microalbuminuria was low overall and not different between the 2 groups (Table 1) . Resting HR, resting LVEF, and resting SP/ESV ratio were similar between groups. However, stress LVEF was reduced and peak HR was blunted along with a reduction in exercise capacity in those with a ⌬SP/ESV ratio Յ12 mm Hg/mL/m 2 ( Table 2 ). Impaired stress response is an established feature of subclinical DHD. 14 Reduction of the ⌬SP/ESV ratio was associated with baseline diastolic dysfunction (evidenced by impaired resting early diastolic tissue velocity, Em) but was unrelated to resting systolic tissue velocity (Sm), strain, strain rate, or cIB. A blunted stress Sm response was noted to correlate with a reduced ⌬SP/ESV ratio, reflective of exercise induced systolic dysfunction in these patients (Figure 2 ). However, other echo markers, such as stress Em and stress deformation parameters, were similar between groups ( Table 3 ). In a logistic regression model, stress-related outcomes including change in Sm (⌬Sm) and stress LVEF were independently associated with ⌬SP/ESV ratio ( Table 4 ).
Correlates of Abnormal Peak Pressure-Volume Ratio
For comparison, the same 167 patients were stratified according to peak SP/ESV of Ͼ28 mm Hg/mL/m 2 (nϭ52) or Յ28 mm Hg/mL/m 2 (nϭ115). When analyzing these groups with the same demographic, biochemical, hemodynamic, and echocardiographic variables as used previously, peak SP/ESV ratio correlated with resting and peak HR, resting and stress LVEF and ⌬Sm. However, only resting HR, resting LVEF, and ⌬Sm were independent correlates of peak SP/ESV ratio ( Table 5) .
In contrast to the results with ⌬SP/ESV ratio, baseline rest SP/ESV ratio was not statistically different between groups (Table 2) . However, when stratifying by peak SP/ESV, there was a statistically significant difference in rest SP/ESV Results are from a logistic regression model.
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between groups. Those with a peak SP/ESV Ͼ28 mm Hg/ mL/m 2 had a higher rest SP/ESV than those with peak SP/ESV Յ28 mm Hg/mL/m 2 (15.0Ϯ4.9 versus 10.8Ϯ3.9 mm Hg/ mL/m 2 , PϽ0.001). Variation of rest SP/ESV ratio was independently associated with age, resting HR, and ⌬EF ( Table 6 ).
Both interobserver and intraobserver measurements showed good concordance, with results being reproducible and without significant variability from original observations. Compared with the original results, there was no statistically significant difference in the resting Em, stress Em, resting strain, stress strain, resting SR, stress SR, or cIB when remeasured by the original observer (C.L.J.) or a second observer (RL 
Discussion
Our results show that a ⌬SP/ESV ratio Յ12 mm Hg/mL/m 2 correlates with variables of known prognostic value in subclinical DHD such as advancing age, impaired exercise capacity, chronotropic incompetence, impaired myocardial tissue velocity, and reduced stress LVEF. Of these factors, the stress-related variables of ⌬Sm and stress LVEF are independent correlates of ⌬SP/ESV ratio, highlighting the importance of the stress response in risk stratification of T2DM. This blunted myocardial stress response is consistent with a cardiomyopathic process, analogous to resting diastolic dysfunction. The association of chronotropic incompetence with a lesser increment of the pressure-volume ratio may be reflective of early cardiac autonomic neuropathy. Interestingly, the pressure-volume relationship does not appear to be related to metabolic disturbance. These findings may explain the prognostic significance of the pressure-volume relationship in T2DM. 11 The pressure-volume relationship is relatively poorly associated with standard echocardiographic measures of myocardial dysfunction such as cIB and deformation parameters. Hence, it may represent an alternative noninvasive method with which to detect early subclinical DHD. This may enable targeted therapy to be instituted sooner in the disease process, leading to prevention of DHD progression and ultimately avoiding the long-term constellation of symptoms associated with diabetic cardiomyopathy. The disparity between the pressure-volume relationship and echocardiographic parameters of myocardial dysfunction is likely because individual markers of LV dysfunction identify different pathological processes occurring concurrently within the spectrum of DHD. These processes may include interstitial fibrosis, microvascular disease and cardiac autonomic neuropathy, although the low prevalence of microalbuminuria in our study population overall makes significant underlying microvascular disease unlikely.
The ⌬SP/ESV ratio correlates with more established variables of prognostic significance in T2DM than the peak SP/ESV ratio. Although both ratios are associated with several independent correlates, it is the ⌬SP/ESV ratio that is most strongly linked with peak hemodynamic response and stress systolic function, both of which are central clinical determinants of LV contractility and contractile reserve. A higher rest SP/ESV results in a higher peak SP/ESV, meaning that the ⌬SP/ESV also provides a more independent measure of true contractile reserve unrelated to baseline function than peak SP/ESV. Of note, a higher rest SP/ESV ratio appears to be predicted by factors associated with a negative prognosis in T2DM such as increased age, higher resting HR, reduced exercise capacity, and lower ⌬LVEF. The prognostic significance of this relationship has not been determined, but our findings lend to speculation that maintaining a lower rest SP/ESV ratio may be protective in T2DM. Should this be established, then the rest SP/ESV may provide a further tool with which to risk stratify the T2DM population, independent of the chronotropic techniques required to determine contractile reserve via the change or peak pressure-volume response. 
Limitations
Limitations of this noninvasive study include that peak cuff systolic pressure was used as a surrogate marker of end-systolic pressure. However, there is a close relationship between these 2 variables, 5 and any sampling error is duplicated between rest and stress values thereby not affecting the overall ratio. Although antihypertensive medications were withheld for at least 12 hours before the ExE, there may still have been blunting of the SBP in either group secondary to the longer half-life of certain antihypertensives. However, in this "real world" study this was unavoidable as it was thought to be unethical to withhold proven medical therapy from diabetic subjects. This study is also limited by the evaluation of associations between multiple factors in a small sample size, and that these findings have not been validated in an independent data set.
Conclusion
An abnormal ⌬SP/ESV ratio response to exercise is predicted by established features of subclinical DHD and probably explains the prognostic significance of this pressure-volume relationship in T2DM. The ESPVR appears to be poorly associated with echocardiographic markers of myocardial dysfunction and may reflect that different pathological processes are being identified which concurrently contribute to the spectrum of myocardial dysfunction in T2DM. The ⌬SP/ESV appears to be a better marker of contractility than peak SP/ESV because it is most strongly linked with peak hemodynamic response and stress systolic function, both of which are central determinants of contractile reserve.
